Mdma/MDA reagent kits part number: 10024631PSC CD: 6550
Ended Awarded
- Contract number
- N6854625FA084
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $12,518
Award facts
- Contract value 100% obligated
- $12,518.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fremont, CA 94538, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Navy Bureau of Medicine and Surgery awarded a delivery order to Microgenics Corporation, a clinical diagnostics manufacturer specializing in immunoassay reagent test kits, for MDMA/MDA (methylenedioxy methamphetamine/methamphetamine) reagent kits valued at $12,518.40. The contract, awarded on August 21, 2025, with an ultimate completion date of December 9, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Microgenics Corporation, operating through its Clinical Diagnostics Division from its Fremont, California facility, will deliver these specialized diagnostic reagents designed for substance detection and medical screening purposes in support of the Department of Defense Drug Demand Reduction Program.
This delivery order is executed under one of Microgenics' existing indefinite delivery/indefinite quantity (IDIQ) contracts for MDMA/MDA reagent kits valued at $1,154,822.40, which provides a comprehensive framework for the Navy Bureau of Medicine and Surgery to procure critical diagnostic supplies on an as-needed basis. The award reflects Microgenics' established competitive position in the federal marketplace, as evidenced by its multiple IDIQ contracts for various immunoassay reagent kits supporting substance abuse testing programs across military and veterans healthcare systems. As a subsidiary of Thermo Electron Corporation, Microgenics maintains a strong track record supplying diagnostic reagents to the Department of Defense and Veterans Affairs agencies for detecting controlled substances including opiates, benzodiazepines, amphetamines, and other drugs used in clinical toxicology screenings.
Quick answers
Who was awarded contract N6854625FA084?
N6854625FA084 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on August 21, 2025.
How much is contract N6854625FA084 worth?
The government has obligated $12,518 on N6854625FA084.
Is contract N6854625FA084 an order under another contract?
Yes. N6854625FA084 is a delivery order under N0018924DZ018, an indefinite delivery contract.
Was contract N6854625FA084 competed?
The extent of competition for N6854625FA084 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award